MMSET Inhibitor

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

  • Myeloma Service
  • 23-222

Arms / Cohorts

Experimental, Part A:Dose Escalation: KTX-1001

Accepting patients

Experimental, Part B:Dose Expansion: KTX-1001

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.